261 related articles for article (PubMed ID: 29782529)
1. Molecular effect of an OPTN common variant associated to Paget's disease of bone.
Silva IAL; Conceição N; Gagnon É; Brown JP; Cancela ML; Michou L
PLoS One; 2018; 13(5):e0197543. PubMed ID: 29782529
[TBL] [Abstract][Full Text] [Related]
2. Effect of genetic variants of OPTN in the pathophysiology of Paget's disease of bone.
Silva IAL; Conceição N; Gagnon É; Caiado H; Brown JP; Gianfrancesco F; Michou L; Cancela ML
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):143-151. PubMed ID: 28993189
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent.
Lucas GJ; Hocking LJ; Daroszewska A; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Meier C; Hooper MJ; Ralston SH
J Bone Miner Res; 2005 Feb; 20(2):227-31. PubMed ID: 15647816
[TBL] [Abstract][Full Text] [Related]
5. Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone.
Michou L; Conceição N; Morissette J; Gagnon E; Miltenberger-Miltenyi G; Siris ES; Brown JP; Cancela ML
Bone; 2012 Oct; 51(4):720-8. PubMed ID: 22796589
[TBL] [Abstract][Full Text] [Related]
6. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
[TBL] [Abstract][Full Text] [Related]
7. Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States.
Rhodes EC; Johnson-Pais TL; Singer FR; Ankerst DP; Bruder JM; Wisdom J; Hoon DS; Lin E; Bone HG; Simcic KJ; Leach RJ
Calcif Tissue Int; 2008 Apr; 82(4):271-7. PubMed ID: 18379713
[TBL] [Abstract][Full Text] [Related]
8. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
[TBL] [Abstract][Full Text] [Related]
10. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.
Hocking LJ; Lucas GJ; Daroszewska A; Mangion J; Olavesen M; Cundy T; Nicholson GC; Ward L; Bennett ST; Wuyts W; Van Hul W; Ralston SH
Hum Mol Genet; 2002 Oct; 11(22):2735-9. PubMed ID: 12374763
[TBL] [Abstract][Full Text] [Related]
11. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone.
Morissette J; Laurin N; Brown JP
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P38-44. PubMed ID: 17229007
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone.
Albagha OM; Visconti MR; Alonso N; Langston AL; Cundy T; Dargie R; Dunlop MG; Fraser WD; Hooper MJ; Isaia G; Nicholson GC; del Pino Montes J; Gonzalez-Sarmiento R; di Stefano M; Tenesa A; Walsh JP; Ralston SH
Nat Genet; 2010 Jun; 42(6):520-4. PubMed ID: 20436471
[TBL] [Abstract][Full Text] [Related]
13. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's Disease.
Obaid R; Wani SE; Azfer A; Hurd T; Jones R; Cohen P; Ralston SH; Albagha OME
Cell Rep; 2015 Nov; 13(6):1096-1102. PubMed ID: 26527009
[TBL] [Abstract][Full Text] [Related]
14. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
[TBL] [Abstract][Full Text] [Related]
15. The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.
Seton M; Hansen M; Solomon DH
Calcif Tissue Int; 2016 May; 98(5):489-96. PubMed ID: 26713335
[TBL] [Abstract][Full Text] [Related]
16. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
17. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
[TBL] [Abstract][Full Text] [Related]
18. The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
Chung PY; Beyens G; Boonen S; Papapoulos S; Geusens P; Karperien M; Vanhoenacker F; Verbruggen L; Fransen E; Van Offel J; Goemaere S; Zmierczak HG; Westhovens R; Devogelaer JP; Van Hul W
Hum Genet; 2010 Dec; 128(6):615-26. PubMed ID: 20839008
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Paget's disease of bone.
Ralston SH; Albagha OM
Curr Osteoporos Rep; 2014 Sep; 12(3):263-71. PubMed ID: 24988994
[TBL] [Abstract][Full Text] [Related]
20. Thirteen Chinese patients with sporadic Paget's disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis.
Gu JM; Zhang ZL; Zhang H; Hu WW; Wang C; Yue H; Ke YH; He JW; Hu YQ; Li M; Liu YJ; Fu WZ
J Bone Miner Metab; 2012 Sep; 30(5):525-33. PubMed ID: 22491873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
